Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
Tradeweb is a high-margin marketplace exposed to fixed income electronic trading and institutional flow. With $1.1B in free cash flow, durable revenue acceleration, and a conservative valuation setup, the stock can climb to $163.20 (about 65% upside) over the next 180 trading days if volumes normalize and multiple expansion follows. This trade lays…
monday.com's AI Work Platform and rising enterprise adoption could let the company move from work-management tool to a governance layer across enterprise tooling. Fundamentals remain solid (24% revenue growth, expanding enterprise customers, profitability improvements) while the stock trades at an attractive ~2.6x implied P/S on FY26 guidance. This…
Summit Therapeutics (SMMT) is a buy into the 11/14/2026 PDUFA for ivonescimab. The drug’s Phase 3 program showed an overall survival benefit versus chemotherapy and partner data have been described as impressive, giving the stock a clear binary upside if the FDA grants approval. The company’s current market cap is ~$12.1B while the fundamentals sho…
<p>Universal Music Group's core asset is intellectual property: recorded masters and publishing. That ownership creates recurring cashflow that is resilient to cycles in advertising and live performance, and today there are fresh distribution and licensing levers available to expand revenue per song. This idea lays out a long trade with defined ris…
VinFast is executing the geographic pivot I expected: factory expansion in Southeast Asia, product launches in India, and partnerships on autonomy and charging. The stock is inexpensive on a market-cap basis relative to growth optionality at $7.37B market cap, technicals show constructive momentum, and short interest remains elevated — creating asy…
Fortress Biotech (FBIO) trades at a market capitalization that looks to underappreciate its liquid assets, newly realized sale proceeds and recurring royalty streams. The stock is volatile and speculative, but the combination of a net cash-heavy balance sheet (enterprise value negative), an ongoing commercial launch and a 2.5% royalty on an FDA-app…
Centene (CNC) looks attractively valued on cash flow metrics despite membership declines. We lay out a long trade targeting $75 with a $61 stop, arguing that Medicare rate increases, cost cutting and a $7.1B FCF cushion give the company time to rebase margins and membership. The plan is for a long-term hold of roughly 180 trading days while watchin…
Cytokinetics' MYQORZO (aficamten) has cleared the hardest step - FDA approval and initial commercial launch - and early revenue and prescribing patterns suggest the drug can scale into a meaningful hypertrophic cardiomyopathy (HCM) franchise. The stock is trading at $83.26 today, reflecting high expectations. This trade idea targets label expansion…
Advanced Energy (AEIS) is benefiting from AI-led data center spending and a cyclical rebound in semiconductor equipment. Recent beats and double-digit top-line growth, combined with management guidance for strong data-center traction, support a mid-term swing trade. Entry at current levels with a disciplined stop preserves reward-to-risk against a …
Embraer looks attractive as a long trade today. A recovery in regional and business jet deliveries, steady defense demand, and an improving supply-chain backdrop give the stock asymmetric upside versus a clear downside buffer. Enter at $22.50, stop $18.00, target $30.00 over a long-term horizon (180 trading days).
Atmos Energy (ATO) combines regulated natural gas distribution scale with steady EPS and a clear dividend policy. Recent operational momentum and an attractive risk/reward near $177 make a mid-term swing trade compelling, with a target toward prior highs around $192.50 and a tight stop under $170 to protect capital.
LIME (LIME) looks like a misunderstood micro-mobility play. With improving unit economics, a cleaner balance sheet and several near-term catalysts, I expect a re-rating over the next 45 to 180 trading days. This trade idea lays out a clear entry, stop and target, plus the reasons and risks behind the call.
Generac has transformed into a key supplier for AI data centers, driving rapid multiple expansion. The business beats are tangible — commercial growth of 28% and raised guidance — but the market is already paying premium multiples (P/E ~67, EV/EBITDA ~26). This trade idea lays out a mid-term short with precise entry, stop and target, plus catalysts…
Netflix ($NFLX) has been punished recently on cautious guidance, but the company still posted record quarterly revenue, strong cash flow and high profitability. Technicals show oversold conditions while catalysts - sports rights, ad-tier expansion, gaming and analyst upgrades - can restore sentiment. We recommend buying at current levels with a mid…
PayPal remains a top-of-wallet payments franchise with multiple execution levers. This trade buys optionality on ongoing product monetization and fee recovery while keeping risk defined. Enter $70, stop $58, target $95 over a 180 trading day horizon.
IREN is a vertically integrated, renewable-powered data center operator that just crossed an implied $4 billion ARR threshold. With a market cap of roughly $17.98B and an enterprise value of $16.50B, the stock looks positioned for a meaningful re-rating if utilization and long-term contracts continue to scale. This trade idea sets a disciplined ent…
AAR (AIR) is an attractive buy after a sharp intraday pullback. The company is benefiting from accelerating parts sales and MRO demand, has manageable leverage, and still trades well below an aggressive growth-adjusted valuation. Our trade plan buys the dip around $126.62 with a $150 target and an $118 stop, sized for a mid-term horizon as the afte…
Oscar Health rallied to a new multiple after guidance that points to an operating-profit inflection. The company is trading below 1x revenue with meaningful free cash flow, but the next leg of gains requires steady claims trends, disciplined underwriting and membership retention. This is a long-term trade idea: enter near current levels, cut losses…
Stifel Financial (SF) is trading below its recent highs on sentiment tied to cash-flow fears. Fundamentals - low leverage, solid free cash flow, and a reasonable P/E - argue the pullback is an entry opportunity. This trade idea lays out an explicit mid-term plan with entry, stop, and target.
Orchestra BioMed (OBIO) is approaching a binary moment: the first of two pivotal readouts for its AVIM and Virtue programs is expected in the coming months. The stock, trading at roughly $3.60 and with a market cap of about $217M, is small and volatile but offers asymmetric upside if clinical data beats expectations. This trade idea lays out an act…
Micron has rallied hard on fresh forecasts for rising memory prices and capacity discipline across the industry. Fundamentals - strong free cash flow, high ROE, and minimal leverage - back the rally. This trade idea outlines an actionable long with exact entry, stop and target, a mid-term time horizon (45 trading days), and balanced risk framing.
Aehr Test Systems (AEHR) has pivoted into AI processor testing and wafer-level burn-in where hyperscalers are struggling to secure validated parts. Strong bookings, a growing backlog and technical momentum create a time-boxed trade. This idea outlines an entry, stop and target for a mid-term (45 trading days) swing while calling out valuation, exec…
Carnival (CCL) is trading near $26 after a late-June guidance scare tied to fuel and geopolitical uncertainty. The headline risk is real - fuel and demand visibility have worsened - but the company reported a record revenue quarter ($6.66B) and generated $3.2B of free cash flow, with deposits at a record $9B and meaningful debt reduction. At ~12x e…
KeyCorp (KEY) looks attractively priced after management authorized a $3.0 billion buyback and continued to pay a healthy quarterly dividend. With a market cap near $24.8B, a P/E around 13.7 and P/B roughly 1.24, the stock offers upside if net interest income and fee lines keep improving. This trade idea outlines a mid-term (45 trading days) swing …
Ondas (ONDS) just reset the narrative: Q1 revenue shock, a $450M+ backlog, and two strategic acquisitions (Omnisys and Cyberhawk) that accelerate recurring revenue and margins. The market is focused on parabolic share moves; we see a rational risk/reward to own a tactical long over the next 45 trading days into Q3 catalysts. Entry $8.25, target $15…
